Marvin 03151215572D 27 29 0 0 1 0 999 V2000 8.4178 -9.8942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.4178 -9.0692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.7033 -10.3067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.7033 -8.6567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.9888 -9.8942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.9888 -9.0692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.8468 -9.8942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.8468 -9.0692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.1323 -10.3067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.1323 -8.6567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.5612 -10.3067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.2757 -9.8942 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 10.5612 -11.1317 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 11.9902 -10.3067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.7054 -9.8947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.3723 -10.3805 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 12.9615 -9.1104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.0403 -9.8965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.7866 -9.1115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.3711 -11.2055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.6561 -11.6170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.6549 -12.4420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.9399 -12.8535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.1346 -11.1317 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 8.4190 -11.5392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.1346 -7.8317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.1346 -7.0067 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3 1 2 0 0 0 0 4 2 2 0 0 0 0 5 3 1 0 0 0 0 6 4 1 0 0 0 0 6 5 2 0 0 0 0 8 7 1 0 0 0 0 9 7 2 0 0 0 0 10 8 2 0 0 0 0 1 9 1 0 0 0 0 2 10 1 0 0 0 0 2 1 1 0 0 0 0 7 11 1 0 0 0 0 11 12 1 0 0 0 0 11 13 2 0 0 0 0 12 14 1 0 0 0 0 15 14 1 0 0 0 0 15 16 1 0 0 0 0 15 17 1 0 0 0 0 18 16 1 0 0 0 0 19 17 1 0 0 0 0 19 18 1 0 0 0 0 16 20 1 0 0 0 0 20 21 1 0 0 0 0 21 22 1 0 0 0 0 22 23 1 0 0 0 0 9 24 1 0 0 0 0 24 25 1 0 0 0 0 10 26 1 0 0 0 0 26 27 3 0 0 0 0 M END > CHEBI:64191 > nafadotride > A naphthalenecarboxamide resulting from the formal condensation of the carboxylic acid group of 4-cyano-1-methoxynaphthalene-2-carboxylic acid with the primary amino group of 1-(1-butylpyrrolidin-2-yl]methanamine. It is a highly potent, competitive, preferential dopamine D3 receptor antagonist, centrally active upon systemic administration. > 3 > nafadotride; (+-)-nafadotride > N-[(1-butylpyrrolidin-2-yl)methyl]-4-cyano-1-methoxynaphthalene-2-carboxamide > C22H27N3O2 > 365.46870 > 365.21033 > 0 > CCCCN1CCCC1CNC(=O)c1cc(C#N)c2ccccc2c1OC > InChI=1S/C22H27N3O2/c1-3-4-11-25-12-7-8-17(25)15-24-22(26)20-13-16(14-23)18-9-5-6-10-19(18)21(20)27-2/h5-6,9-10,13,17H,3-4,7-8,11-12,15H2,1-2H3,(H,24,26) > IDZASIQMRGPBCQ-UHFFFAOYSA-N > 149649-22-9 > 8356954 > 149649-22-9 > LSM-1755 > Nafadotride > 8531087; 9252981 $$$$